UnknownNCT02066012

MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Clermont-Ferrand
Principal Investigator
Marc RUIVARD
University Hospital, Clermont-Ferrand
Intervention
dysmetabolic iron overload syndrome(other)
Enrollment
60 target
Eligibility
18 years · All sexes
Timeline
20142014

Study locations (1)

Collaborators

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02066012 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials